Geographical Location
stringclasses
54 values
Report Date
stringclasses
1 value
MDS Item Question/Description
stringclasses
828 values
MDS Item Response
stringclasses
303 values
Percent
stringlengths
1
5
Total Residents
stringlengths
1
7
California
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
97.04
525
California
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
2.96
16
Colorado
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
78.26
18
Colorado
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Connecticut
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Connecticut
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.89
70
Delaware
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
100
21
Delaware
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
District of Columbia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
District of Columbia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Florida
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
97.45
382
Florida
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Georgia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Georgia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.1
97
Hawaii
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Hawaii
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Idaho
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Idaho
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Illinois
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.17
256
Illinois
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
4.83
13
Indiana
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Indiana
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
98.1
103
Iowa
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.35
41
Iowa
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Kansas
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
90.7
39
Kansas
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Kentucky
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
97.18
69
Kentucky
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Louisiana
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
98.85
86
Louisiana
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Maine
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Maine
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Maryland
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
97.46
115
Maryland
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Massachusetts
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.14
137
Massachusetts
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Michigan
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
91.34
116
Michigan
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
8.66
11
Minnesota
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
92.86
39
Minnesota
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Mississippi
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
96.97
64
Mississippi
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Missouri
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
96.63
86
Missouri
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Montana
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Montana
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Nebraska
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
100
25
Nebraska
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Nevada
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95
19
Nevada
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
New Hampshire
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
93.75
15
New Hampshire
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
New Jersey
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
93.84
274
New Jersey
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
6.16
18
New Mexico
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
100
16
New Mexico
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
New York
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.8
502
New York
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
4.2
22
North Carolina
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
92.73
102
North Carolina
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
North Dakota
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
North Dakota
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Ohio
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
97.58
202
Ohio
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Oklahoma
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
92.59
50
Oklahoma
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Oregon
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Oregon
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
88.24
15
Pennsylvania
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
97.41
188
Pennsylvania
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Puerto Rico
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Puerto Rico
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Rhode Island
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
92.86
13
Rhode Island
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
South Carolina
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
South Carolina
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
98.31
58
South Dakota
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
100
11
South Dakota
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Tennessee
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
91.11
82
Tennessee
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Texas
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
96.1
222
Texas
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Utah
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Utah
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Vermont
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Vermont
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Virgin Islands
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Virgin Islands
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
Virginia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
96.94
95
Virginia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Washington
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
97.96
48
Washington
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
West Virginia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.45
21
West Virginia
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Wisconsin
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
94.64
53
Wisconsin
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Wyoming
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
*
*
Wyoming
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
*
*
National Total
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
Yes
95.86
4469
National Total
Q1, 2025
A2122D: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Paper-based (e.g., fax, copies, printouts)
No
4.14
193